You searched for "patients"

3924 results found

BT as an effective alternative treatment for small angle consecutive exotropia

In this study, the authors evaluate the efficacy of botulinum toxin A (BTA) as a treatment option for consecutive exotropia. This was a retrospective review of 34 patients; 23 female and 11 male. Age at BTA was a mean of...

Biomarkers in thyroid eye disease

An ideal biomarker is sensitive, specific, easily assessable and clinically relevant. This study looked at the presence of inflammatory cytokines present in the tear film of healthy controls, thyroid patients without eye disease (non-TED) and those with thyroid eye disease...

Use of reduced volume BT as a treatment option for acute onset comitant esotropia

In this study, the effectiveness and safety of botulinum toxin (BT) for patients with acute acquired comitant esotropia (AACE) and deviation ≤25PD was investigated with comparison of results to conservative prism therapy. Botulinum toxin was undertaken without electromyographic guidance and...

Idebenone for Leber hereditary optic neuropathy

The authors present a meta-analysis of studies reporting the effects of idebenone treatment on visual acuity (VA) in patients with Leber hereditary optic neuropathy (LHON), the most common inherited mitochondrial disorder. They included randomised controlled trials, non-randomised controlled trials and...

Surgical outcomes for acute acquired comitant esotropia with vs without prism adaptation testing

The aim of this study was to assess the efficacy of preoperative prism adaptation test (PAT) in cases of acute acquired comitant esotropia (AACE) in an Indian population. This was a prospective study of 40 patients. 20 patients had 1...

Non-infectious Uveitis: Well Known, Weird and Wonderful meets You, Me and the Balloons

Installation view from Manchester International Festival 2023 exhibition Yayoi Kusama: You, Me and the Balloons at Aviva Studios. Images © David Levene. On an uncharacteristically salubrious 5 July 2023, the date of the 75th Anniversary of the UK’s NHS, a...

Glaukos Launches iStent infinite® in the UK Following MDR Approval

Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...

Deliberate darkness: The systematic weaponisation of blinding in global protests

As eyecare professionals, we spend our entire professional lives fighting to preserve light. We train to master the delicate microscopic topography of the cornea, the retina and the optic nerve, all with the objective of saving our patients from the...

Cementing a VISION 2020 LINK partnership between Blantyre and Liverpool – building capacity for DR services alongside research

Malawi is a small land-locked country in eastern Africa with a growing population of over 17 million people. About 45% of the population is aged 14 or under; only 5% are aged 60 or over. The gross national income per...

Understanding vasoproliferative retinal tumours

Syed Irtiza Ali Shah explores this rare and unusual condition through a fascinating case presentation. Vasoproliferative tumours of the retina (VPTR) are a vascular mass with an associated exudative retinopathy alongside the presence of minimally dilated feeder vessels. This is...

UK Eye Genetics Group Annual Conference

by Chloe M. Stanton, UK-EGG Treasurer, MRC Human Genetics Unit, Institute of Genetics and Cancer, University of Edinburgh Delegates including ophthalmic clinicians, clinical geneticists, genetic counsellors and research scientists travelled to Edinburgh from across the UK and Europe to attend...

Optegra celebrates 15th anniversary and announces expansion plans

Specialist eye hospital Optegra marks its 15th anniversary this month, having opened its first UK hospital in Guildford in 2008.